SecBot SecBot
SECBOTREPLAY Home › Report › ABEO

ABEO · $30M PIPE + asset buy

ABEONA THERAPEUTICS INC. · 8-K filed Nov 9, 2026 at 06:30 ET

At the news

BEARISHIMPACT 6/10

8-K filed Nov 9, 2026 at 06:30 ET

Abeona Therapeutics entered into a securities purchase agreement with institutional investors to sell up to 8,000,043 shares and/or pre-funded warrants at $3.75 per share, raising approximately $30M in gross proceeds. Simultaneously, the company completed an asset acquisition from Ellodi Pharmaceuticals for $20M in stock, funded by the PIPE. The combined transactions dilute existing shareholders by roughly 13-15% based on the $224M market cap, while the activist stake (6.1%) filed 17 days ago adds pressure for strategic change.

  • PIPE of up to 8,000,043 shares/pre-funded warrants at $3.75/share, raising ~$30M
  • Asset purchase from Ellodi Pharmaceuticals for $20M in stock (upfront shares)
  • Activist James Russell disclosed 6.1% stake 17 days prior, requesting board changes
  • Morgan Stanley acted as placement agent

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access